- Supported exchanges /
- F /
- 5DG.F
OCUMENSION THER.DL-00001 (5DG F) stock market data APIs
Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. It discovers, develops, and commercializes therapies for ophthalmic patients. Its portfolio includes products and drugs for the treatment of chronic non-infectious uveitis, blepharitis, infective and allergic conjunctivitis, diabetic macular edema, dry eye, glaucoma and ocular hypertension, postoperative inflammation, choroidal neovascularization, bacterial conjunctivitis, retinitis pigmentosa, acute glaucoma, age-related macular degeneration, cornea graft rejection, myopia, and optic neuritis. It had various drug assets in its portfolio. The company was founded in 2017 and is headquartered in Suzhou, the People's Republic of China.
OCUMENSION THER.DL-00001 Financial Data Overview
| 0.66 | |
| 0.66 | |
| - | |
| 0.66 | |
| 0.66 | |
| 0.466-0.9 | |
| 0 | |
| 0 | |
| 0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
OCUMENSION THER.DL-00001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get OCUMENSION THER.DL-00001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get OCUMENSION THER.DL-00001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
